Greenwich LifeSciences (NASDAQ:GLSI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.

Open	$11.59
Close	$11.76
Volume / Avg.	11.91K / 32.95K
Day Range	$11.54 - $11.80
52 Wk Range	10.52 - 21.44
Market Cap	$152.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	10.41%
Days to Cover	18.28

Recent News

Over $1M Bet On United Security Bancshares? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Avi Kapoor

Why Greenwich Lifesciences (GLSI) Stock Is Skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$11.59
Close	$11.76
Volume / Avg.	11.91K / 32.95K
Day Range	$11.54 - $11.80
52 Wk Range	10.52 - 21.44
Market Cap	$152.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	10.41%
Days to Cover	18.28

About Greenwich LifeSciences Inc

Sector

Health Care

Industry

Biotechnology

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Greenwich LifeSciences (GLSI) stock?

You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.

View our list of the best stock brokerages

Who are Greenwich LifeSciences (GLSI) competitors?

Other companies in Greenwich LifeSciences’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP), Fate Therapeutics (NASDAQ:FATE) and Genelux (NASDAQ:GNLX).

What is the forecast, or price target, for Greenwich LifeSciences (GLSI) stock?

Greenwich LifeSciences has a consensus price target of $38.00.

What is the current price for Greenwich LifeSciences (GLSI)?

The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $11.5999 last updated February 26, 2025 at 9:19 AM EST.

Does Greenwich LifeSciences (GLSI) pay a dividend?

There are no upcoming dividends for Greenwich LifeSciences.

When is Greenwich LifeSciences (NASDAQ:GLSI) reporting earnings?

Greenwich LifeSciences’s Q1 earnings are confirmed for Monday, May 19, 2025.

Is Greenwich LifeSciences (GLSI) going to split?

There is no upcoming split for Greenwich LifeSciences.

What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Greenwich LifeSciences

Greenwich LifeSciences (GLSI) Forecast